N
Nexalin Technology, Inc. (NXL)
NCM – Real Time Price. Currency in USD
0.34
+0.00 (0.68%)
At close: May 12, 2026, 4:00 PM EDT
0.34
-0.00 (-0.03%)
After-hours: May 12, 2026, 7:06 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.34
+0.00 (0.68%)
At close: May 12, 2026, 4:00 PM EDT
0.34
-0.00 (-0.03%)
After-hours: May 12, 2026, 7:06 PM EDT
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
| Name | Position |
|---|---|
| Dr. David Owens M.D. | Chief Medical Officer, Member of Scientific Advisory Board & Director |
| Mr. John Patrick Claude | Co-Founder and Director of Engineering & Development |
| Mr. Justin Van Fleet CPA | Chief Financial Officer |
| Mr. Mark White | President, CEO & Director |
| Ms. Carolyn Shelton | Executive VP of Clinical, Quality & Regulatory Affairs |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 10-Q | nexalintechno_10q.htm |
| 2026-04-22 | 8-K | nexalintec_8k.htm |
| 2026-03-25 | 10-K | nexalintech_10k.htm |
| 2026-02-25 | 8-K | nexalintec_8k.htm |
| 2026-01-23 | 8-K | nexalintech_8k.htm |
| 2025-12-05 | 8-K | nexalintech_8k.htm |
| 2025-11-14 | 10-Q | nexalintechno_10q.htm |
| 2025-10-15 | 8-K | nexalintech_8k.htm |
| 2025-09-23 | 10-K/A | nexalintech_10ka.htm |
| 2025-09-22 | 8-K | nexalintech_8k.htm |